Healthcare | June 30, 2025
Fredun Pharmaceuticals acquires One Pet Stop to foray into pet care market
The pet dog population alone is expected to increase from 21.4 million in 2019 to 51.5 million by 2028
The pet dog population alone is expected to increase from 21.4 million in 2019 to 51.5 million by 2028
The approval in China is supported by a robust local clinical development program confirming the drug’s safety, tolerability, and efficacy profile
Acquisition to be followed by merger; strengthens Torrent’s IPM market presence
The company has been awarded a contract for the supply of essential pharmaceutical formulations to government health institutions across Rajasthan
Review will evaluate effectiveness in treating alcohol withdrawal syndrome and supporting abstinence, as well as measures to mitigate risk of abuse
The inspection concluded with zero Form 483 observations
The company's decision to withdraw the MAA was due to the timing of the availability of Chemistry Manufacturing and Controls
The NovaSeq X system features Illumina's cutting-edge XLEAP-SBS chemistry, offering unmatched throughput, accuracy, and sustainability
TEVIMBRA is a uniquely designed anti-PD-1 monoclonal antibody developed by BeiGene (now BeOne Medicines)
This collaboration ensures that patients receive comprehensive care, including emotional and psychological support throughout their fertility journey
Subscribe To Our Newsletter & Stay Updated
